しずおかCF33 かながわTM364 えどがわAA387×2 かわさきTC767 かながわHI 173 さいたまCY55×2 さいたまOM39 とちぎFB21 ふくおかNA01 よこはまA29 よこはまZR120 さいたまYT220 とちぎYA306 さいたまFL20 いばらぎRJ601×2 みやぎDV79 みやぎNE410 とやまRS87 にいがたKB494 とかちST617 あおもりCC39 続

wewem! yg jualan jiang yan atau sdj especially if you're a zhuyan enthusiast di cf33 please drop your katalog or just say hi bellow, sender mau beli semuanya >< !!

New #JITC article: "Intraperitoneal CF33-hNIS combined with PD-L1 blockade eradicates gastric cancer peritoneal metastases and prevents recurrence via durable T cell memory" jitc.bmj.com/content/14/4/e0… @SanginKim95 @SoCalYuman

Match Day 🏉 📍Kenfig Hill RFC, CF33 6BU ⏰ 19:15 🆚 Llantrisant RFC 🏆 Silver Ball #UppaMaen #WRUcommunity

今日の謎の読み物は録音と本番の違いでえす🙌✨ 【CF33日目🧡】録音と本番の違い v-cro.jp/studios/207712/repo… #ぶいクラ！

🔵⚫️WRU CHAMPIONSHIP WEST ⚫️ League action returns this weekend as we hit the road to face @KenfigHillRFC 👕 @KenfigHillRFC 🏟️ Croft Goch Kenfig Hill,CF33 6BU 📆 Saturday 31st January 2026 ⏰ Kick-off: 14:30 🏆 @WRUChampionship West #GlasADu #MwyNaChlwb 🔵⚫️

WAR重視でその年の先発出場が多いポジションで選出するとこうなるのか イチロー 95年 CF69/RF61 田口壮 97年 LF102/CF33 長池徳二 69年 RF111/CF18 やっぱ95年のイチロー10.6は凄いな。面白い

Imugene, JW partner on CF33-CD19 for solid tumors @TeamImugene proactiveinvestors.com/compa… #Imugene #OncolyticVirus #BiotechNews #CancerResearch #SolidTumors #ImmunoOncology #JWTherapeutics

We’ve entered into a strategic collaboration with JW Therapeutics 药明巨诺 to evaluate a first-in-class combination therapy for refractory solid tumours. The initiative will combine our onCARlytics (CF33-CD19) platform with JW’s CD19 CAR-T therapy, Carteyva®, in preclinical studies and a Phase 1 investigator-initiated trial in China. This “mark and kill” approach could redefine how we target difficult-to-treat cancers. Read the full $IMU ASX Announcement here: wcsecure.weblink.com.au/pdf/… #ASX #ImmunoOncology #CellTherapy #CAR_T #onCARlytics

⏳🏉 💙🖤🤍 Don’t miss the #MIGHTYWands @GlamWandsRFC Championship Cup 2nd Round match for the 2025 / 26 season: 🏆 Championship Cup 🆚 @KenfigHillRFC 🗓 Sat 25 Oct 2025 ⏰ 1430hrs 🏴󠁧󠁢󠁷󠁬󠁳󠁿 Pisgah Street, Kenfig Hill, CF33 6BU 📌 maps.app.goo.gl/SZc3ago129Rh…

母にこの掃除機買ってあげた。 母曰く「ダ◯ソンの掃除機は掃除の途中でバッテリー切れることがあるからそこが不便」とのこと。 少しは親孝行出来たかな( ﾟДﾟ)y─┛~~ サイクロン式 キャニスター型 クリーナー TORNEO mini ストームグレー VC-CF33(H) amzn.asia/d/5yMdX3w

🎉 Great to join the team and local residents at the official opening of One Stop Pyle Stores this morning! A real boost for our community – more convenience, more choice, and continued local jobs. Wishing the staff every success for the future 👏 📍 Pyle Road, CF33 6PG

There are a couple of companies working on this that I have been following. Instead of mrna, they are using modified virus and modified tcells. CF33 is one that is promising

📣 We're excited to share our August newsletter. In this edition, we highlight continued progress in our azer-cel clinical program, share insights from our latest Q&A with Dr Supriya Gupta, Principal Investigator for Imugene’s azer-cel trial, and introduce our newly appointed Chief Medical Officer, Dr John Byon. 📩 Read the latest here: imugene.com/wp-content/uploa… $IMU #Imugene #ImmunoOncology #CDH17 #CF33 #azer_cel #CancerResearch #Biotech #ASXNews

We’ve received a Notice of Allowance from the US Patent and Trademark Office for our onCARlytics technology, protecting the method of composition and use of CF33-CD19 and its combination with CD19-targeting CAR T therapies through to August 2038. Managing Director and CEO Leslie Chong said, “Imugene receiving this US patent allowance for the CF33-CD19 onCARlytics platform is a crucial step forward for our IP position, with the US being the largest healthcare market in the world. This follows patent allowance in China, an equally large cell therapy market, earlier in 2025.” View the full $IMU #ASX Announcement here: wcsecure.weblink.com.au/pdf/… #IMU #Imugene #Biotech #ASXNews

The Gaffa Doing Bits 🐝 @leeowen28 Feel free to come along next Wednesday 11th June 6:00pm 📍 CF33 4LL

Check out Brent Burns ‘23-24 UD Allure Hockey #CF33 Red-Orange Hurricanes ebay.us/m/twQF6g #eBay via @eBay #TBBCrew #TBBReposts

Wow! 30 years, it’s amazing. I follow all the latest biotech drug development for MBC. I find very promising Avacta AVA6000,(new MBC trial will start in 2026), Imugene Vaxinia, OnCARlytics a CD19-expressing oncolytic virus CF33-CD19, Etira, TransCode Therapeutics, BriaCell

Imugene’s Senior Director, Translational Research, Grey Wilkinson, presented our poster 𝑇𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑜𝑓 𝐶ℎ𝑜𝑙𝑎𝑛𝑔𝑖𝑜𝑐𝑎𝑟𝑐𝑖𝑛𝑜𝑚𝑎 𝑤𝑖𝑡ℎ 𝑡ℎ𝑒 𝑂𝑛𝑐𝑜𝑙𝑦𝑡𝑖𝑐 𝑉𝑖𝑟𝑢𝑠 𝐶𝐹33-ℎ𝑁𝐼𝑆 yesterday at the 2025 Cholangiocarcinoma Foundation Annual Conference (CFAC) in Salt Lake City, Utah. $IMU #IMU #Imugene #CFAC2025 #Cholangiocarcinoma #CF33 #OncolyticVirus #Immunotherapy #CancerResearch

Recruiting: A Phase I, Dose Escalation and Dose Expansion, Safety and Tolerability Study of OnCARlytics (CF33-CD19), Administered Intravenously or Intratumorally in Combination with Blinatumomab in Adults with Metastatic Solid Tumors (OASIS). $IMU #AACR25 clinicaltrials.gov/study/NCT…